新型CD206+巨噬细胞特异性动脉成像策略在HIV感染者中的应用
本研究首次在人体测试了一种巨噬细胞特异性动脉成像技术。离体实验显示锝-99m标记的tilmanocept(99mTc-tilmanocept)与CD206+巨噬细胞共定位。在所有受试者中,高水平摄取与非钙化斑块体积相关(r=0.87;
要点
- 99mTc-tilmanocept可与CD206+巨噬细胞共定位。
- HIV感染者主动脉高水平摄取比例高于非感染者。
- 高水平摄取与非钙化斑块体积相关。
核心结论
- 首次在人体中引入一种巨噬细胞特异性动脉成像技术,可用于评估HIV相关心血管疾病。
研究设计与样本
- 首次人体试验,比较HIV感染者与非HIV感染者的新型动脉成像表现。
主要发现
- 离体实验证实99mTc-tilmanocept与CD206+巨噬细胞共定位。
临床怎么用
- 该技术可能用于无创评估动脉CD206+巨噬细胞,以增进对HIV相关心血管疾病的理解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ability to noninvasively assess arterial CD206+ macrophages may lead to improved understanding of human immunodeficiency virus (HIV)-associated cardiovascular disease. METHODS: We trialed a novel macrophage-specific arterial imaging technique. RESULTS: We demonstrated colocalization between technetium Tc 99m tilmanocept (99mTc-tilmanocept) and CD206+ macrophages ex vivo. In vivo application of 99mTc-tilmanocept single-photon emission computed tomography/computed tomography revealed high-level 99mTc-tilmanocept uptake across 20.4% of the aortic surface volume among HIV-infected subjects, compared with 4.3% among non-HIV-infected subjects (P = .009). Among all subjects, aortic high-level 99mTc-tilmanocept uptake was related to noncalcified aortic plaque volume (r = 0.87; P = .003) on computed tomographic angiography, and this relationship held when we controlled for HIV status. CONCLUSION: These first-in-human data introduce a novel macrophage-specific arterial imaging technique in HIV. CLINICAL TRIALS REGISTRATION: NCT02542371.
引用
- Zanni MV, Toribio M, Wilks MQ, et al. Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals. J Infect Dis. 2017. PMID: 28204544. doi:10.1093/infdis/jix095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。